Developer docs
API playgroundTry for free, no card

Search company profiles

Nuritas

Full company profile

uuid0003hse

Namestring
Nuritas
Legal namestring
Nuritas Ltd
Websiteurl
nuritas.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Nuritas Ltd is a Dublin-based biotechnology company founded in 2014 by Dr. Nora Khaldi that combines artificial intelligence with genomics to discover bioactive peptides in natural food sources such as fava beans and rice. Its core technology is Magnifier NπΦ, a proprietary AI platform purpose-built for peptide biology that screens billions of peptide sequences, predicts biological activity and bioavailability, and supports a six-step discovery process from AI-powered candidate screening through human clinical validation. The company has built the world's largest known library of natural peptides with identified functionalities, numbering over 8 million peptides, and has been issued 56 patents globally.

Nuritas commercializes four primary clinically validated peptide ingredients — PeptiStrong (muscle health), PeptiSleep (sleep quality), PeptiYouth (skin health), and PeptiProtect (topical protection) — alongside a research-stage antimicrobial peptide (PeptiSave). These ingredients are sold B2B, on a quote-based pricing model with multi-year contracts, to consumer brands and formulators that integrate them into functional foods, beverages, supplements, and cosmetics. As of 2025–2026, more than 100 commercial products globally contain Nuritas peptides, with over 200 million doses delivered across more than 31 countries. The company holds FDA GRAS status and Non-Novel Food designations in Canada and the EU, enabling cross-jurisdictional commercialization.

The business operates two GTM motions: direct enterprise field sales to major consumer goods companies (Nestlé, Mars, Givaudan, Sumitomo Corporation, BASF, L'Oréal) and an expanding network of regional distribution partners across Europe (Alifarma, Faravelli, Vivatis Pharma) supplemented by retail distribution in the United States via GNC, Vitamin Shoppe, and direct-to-consumer supplement brands. Revenue is derived from one-time/recurring ingredient sales plus custom peptide discovery partnerships structured as licensing/royalty arrangements. The company has raised approximately $87 million across multiple funding rounds, most recently a $42 million Series C in December 2024 led by M&G Investments and McWin Capital Partners, and is led by a team of scientists, AI specialists, and industry executives with a board and advisory bench that includes former PepsiCo CEO Indra Nooyi.

Short descriptiontext

Nuritas is a Dublin-based biotech that uses its proprietary Magnifier AI platform to discover and clinically validate bioactive peptides from natural food sources, selling these ingredients B2B to consumer brands in supplements, functional foods, beverages, and cosmetics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersDublin, Ireland
HQ citystring
Dublin
HQ countrystring
Ireland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bioactive peptide discovery, AI peptide ingredients, functional food peptides, clinical nutrition ingredients, peptide-based supplements
Industry4 codes
PRIMARYAFAJAKAG
Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYAFAJAHAI
Protein Hydrolysates & Peptides (Enzymatic Hydrolysates, Bioactive Peptides)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
SECONDARYCRADAOAJ
Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids)
SECONDARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Bioactive Peptide Ingredients
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Peptide Ingredient Sales
TypeOne Time License
Description

Sale of proprietary bioactive peptide ingredients (PeptiStrong, PeptiSleep, PeptiYouth, PeptiProtect) to B2B companies for integration into functional foods, beverages, supplements, and cosmetics. Ingredients are sold directly to formulation, R&D, or procurement teams.

nuritas.com
2Custom Peptide Discovery Partnerships
TypeLicensing Royalties
Description

Custom peptide discovery powered by AI for specific health outcomes. Partner companies can access Nuritas's pipeline of intelligent ingredients in development and be first to access next generation ingredients.

nuritas.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Pricing details1 tier
1B2B ingredient sales - quote-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing not publicly disclosed. Direct B2B sales model with quote-based pricing. Ingredients available in various formats including powder, capsules, tablets, and stick packs.

nuritas.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1PeptiStrong
Description

Plant-based peptide ingredient derived from fava beans for muscle health and performance, backed by clinical studies supporting strength, energy, and recovery.

nuritas.com
+4 more records
Core offering1 text field

Nuritas develops and sells clinically validated bioactive peptide ingredients (PeptiStrong®, PeptiSleep™, PeptiYouth™, PeptiProtect®) discovered through its proprietary Magnifier NπΦ™ AI platform. These plant-derived peptide ingredients are sold B2B to consumer-goods companies for formulation into functional foods, beverages, dietary supplements, and cosmetic products, supported by custom peptide discovery partnerships for major brands.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Discovery timeline reduced from 20-70 years to months
+5 more records
Product overview1 text field

Nuritas is a biotechnology company that developed a portfolio of clinically proven, AI-discovered peptide ingredients. The core offering consists of PeptiStrong® (muscle health), PeptiSleep™ (sleep quality), PeptiYouth™ (skin health), and PeptiProtect® (topical protection), all discovered and validated through the company's proprietary Magnifier NπΦ™ AI platform. The company operates as a B2B ingredient supplier, selling clinically validated peptide powders to consumer brands for integration into supplements, functional foods, beverages, and topical products. Over 100 consumer products now contain Nuritas SmartPeptides™, with commercial availability in more than 31 countries.

Product and service6 records
1PeptiStrong®
CategoryMuscle health peptide ingredient
Description

Clinically studied plant-based bioactive peptide ingredient derived from fava beans that supports muscle strength, energy, and recovery. Sold B2B to consumer-goods, sports nutrition, and supplement brands (Cellucor, MuscleTech, Jacked Factory, Designs for Health, Nu Skin, GNC, Vitamin Shoppe) for formulation into functional foods, beverages, and supplements.

2PeptiSleep™
CategorySleep peptide ingredient
Description

Plant-based bioactive peptide ingredient designed to support sleep quality and circadian rhythm, backed by clinical research. Sold B2B to consumer brands for incorporation into sleep-support supplements and functional beverages.

3PeptiYouth™
CategorySkin health peptide ingredient
Description

Plant-based bioactive peptide ingredient derived from rice proteins for skin health and beauty-from-within anti-aging applications. Validated through peer-reviewed research and sold B2B to cosmetics and supplement brands.

4PeptiProtect®
CategoryProtection peptide ingredient
Description

Plant-based peptide ingredient for protective health benefits, used in oral and topical product formats. Sold B2B to consumer brands for protective functional applications.

5PeptiSave™
CategoryAntimicrobial peptide ingredient
Description

Antimicrobial peptide ingredient derived from peas, with demonstrated efficacy against foodborne pathogens including Escherichia coli O157:H7. Published in Frontiers in Microbiology and Food Science & Nutrition. Positioned as a research-stage antimicrobial peptide for food safety applications.

6Custom Peptide Discovery Partnerships
CategoryCustom AI peptide discovery service
Description

B2B service offering where Nuritas applies its Magnifier AI platform to discover novel bioactive peptides tailored to a partner's specified health outcomes. Provides partners with early access to next-generation ingredients and exclusive pipeline opportunities. Customers include BASF Human Nutrition and other major CPG/ingredient companies.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
1MetaboTwin Consortium
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-10
Description

Four-year TKI Agri & Food-funded research consortium led by Wageningen University & Research and Eindhoven University of Technology. Nuritas contributes food peptide ingredients for the world's first Human Dietary Digital Twin project studying metabolic responses to different protein sources.

nuritas.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-24
Description

Double-blinded RCT partnership examining PeptiStrong's ability to support healthy aging in adults aged 60-85, in collaboration with StudySetGo. Results expected Q3 2026.

Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-24
Description

European distribution partner for Spain and Portugal markets.

Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-24
Description

European distribution partner for Italy market.

Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-24
Description

European distribution partner for Poland, Czech Republic, Slovakia, and the three Baltic markets.

6Nestlé
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major consumer goods company partnership for ingredient development and product integration.

nuritas.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major consumer goods company partnership for ingredient development and product integration.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leading flavor and fragrance company partnership for ingredient innovation and product applications.

9Sumitomo Corporation
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Japanese trading company partnership for ingredient distribution and market expansion.

nuritas.com
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partnership collaboration with BASF Human Nutrition. Vice President Tina Low quoted on consumer demand for plant-based solutions for sports-related inflammation.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight8 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Phytolon uses precision fermentation to produce natural food colors from plants, an emerging player in AI/biotech-enabled food ingredients with similar go-to-market into CPG.

TypeDirect peer
Description

Brightseed uses AI to discover bioactive compounds in plants for food, beverage, and supplement applications, closely mirroring Nuritas' AI-discovered bioactive peptide model and B2B ingredient commercialization approach.

TypeDirect peer
Description

Shiru applies AI to discover and design novel food proteins and ingredients, comparable to Nuritas' Magnifier-driven peptide discovery and B2B ingredient supply into CPG.

TypeDirect peer
Description

Geltor produces animal-free functional proteins (including collagen-equivalent peptides) via precision fermentation, competing with Nuritas in the bioactive protein/peptide ingredient space for beauty and nutrition applications.

TypeEmerging player
Description

Amai uses computational protein design and AI to create sweet-protein and functional food proteins, an emerging peer that overlaps with Nuritas' AI-driven bioactive ingredient pipeline.

TypeEmerging player
Description

MycoTechnology uses fermentation platforms to develop plant-based functional food ingredients, an adjacent emerging player in the CPG ingredient space where Nuritas competes.

TypeBroad incumbent
Description

ADM is a global CPG ingredient powerhouse with a fast-growing Health & Wellness and microbiome/probiotic portfolio, representing a broad incumbent competitor in the branded functional-ingredient space.

TypeBroad incumbent
Description

Kerry is a global taste and nutrition ingredient supplier serving the same CPG and supplement customers as Nuritas, with broader portfolios across functional foods and beverages.

TypeBroad incumbent
Description

International Flavors & Fragrances has a large Health & Biosciences division producing bioactive ingredients (including proteins, enzymes, and cultures) for food, beverage, and supplement customers, overlapping with Nuritas' customer set.

TypeBroad incumbent
Description

BASF is a global nutrition ingredient supplier and an existing Nuritas partner; it competes in the broader bioactive and plant-based ingredient market that Nuritas addresses.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors17 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nuritas

Bioactive Peptide Ingredientsnuritas.com

Nuritas is a Dublin-based biotech that uses its proprietary Magnifier AI platform to discover and clinically validate bioactive peptides from natural food sources, selling these ingredients B2B to consumer brands in supplements, functional foods, beverages, and cosmetics.

What Nuritas does

Nuritas Ltd is a Dublin-based biotechnology company founded in 2014 by Dr. Nora Khaldi that combines artificial intelligence with genomics to discover bioactive peptides in natural food sources such as fava beans and rice. Its core technology is Magnifier NπΦ, a proprietary AI platform purpose-built for peptide biology that screens billions of peptide sequences, predicts biological activity and bioavailability, and supports a six-step discovery process from AI-powered candidate screening through human clinical validation. The company has built the world's largest known library of natural peptides with identified functionalities, numbering over 8 million peptides, and has been issued 56 patents globally.

Nuritas commercializes four primary clinically validated peptide ingredients — PeptiStrong (muscle health), PeptiSleep (sleep quality), PeptiYouth (skin health), and PeptiProtect (topical protection) — alongside a research-stage antimicrobial peptide (PeptiSave). These ingredients are sold B2B, on a quote-based pricing model with multi-year contracts, to consumer brands and formulators that integrate them into functional foods, beverages, supplements, and cosmetics. As of 2025–2026, more than 100 commercial products globally contain Nuritas peptides, with over 200 million doses delivered across more than 31 countries. The company holds FDA GRAS status and Non-Novel Food designations in Canada and the EU, enabling cross-jurisdictional commercialization.

The business operates two GTM motions: direct enterprise field sales to major consumer goods companies (Nestlé, Mars, Givaudan, Sumitomo Corporation, BASF, L'Oréal) and an expanding network of regional distribution partners across Europe (Alifarma, Faravelli, Vivatis Pharma) supplemented by retail distribution in the United States via GNC, Vitamin Shoppe, and direct-to-consumer supplement brands. Revenue is derived from one-time/recurring ingredient sales plus custom peptide discovery partnerships structured as licensing/royalty arrangements. The company has raised approximately $87 million across multiple funding rounds, most recently a $42 million Series C in December 2024 led by M&G Investments and McWin Capital Partners, and is led by a team of scientists, AI specialists, and industry executives with a board and advisory bench that includes former PepsiCo CEO Indra Nooyi.

Nuritas firmographics

Firmographics
Name
Nuritas
Legal name
Nuritas Ltd
Website
https://nuritas.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
51–100 employees
Short description
Nuritas is a Dublin-based biotech that uses its proprietary Magnifier AI platform to discover and clinically validate bioactive peptides from natural food sources, selling these ingredients B2B to consumer brands in supplements, functional foods, beverages, and cosmetics.
Ownership category
akta.pro rank

Nuritas industry classification

Industry
Product category
Bioactive Peptide Ingredients
NAICS
Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYAFAJAKAG
Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYAFAJAHAI
Protein Hydrolysates & Peptides (Enzymatic Hydrolysates, Bioactive Peptides)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
SECONDARYCRADAOAJ
Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids)
SECONDARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)

Keywords

  • Bioactive peptide discovery
  • AI peptide ingredients
  • Functional food peptides
  • Clinical nutrition ingredients
  • Peptide-based supplements

Where Nuritas is headquartered

Location

Headquarters

HQ city
Dublin
HQ country
Ireland
HQ region
Europe

Offices2 records

Markets served

Nuritas business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Peptide Ingredient Sales: Sale of proprietary bioactive peptide ingredients (PeptiStrong, PeptiSleep, PeptiYouth, PeptiProtect) to B2B companies for integration into functional foods, beverages, supplements, and cosmetics. Ingredients are sold directly to formulation, R&D, or procurement teams.
  2. Custom Peptide Discovery Partnerships: Custom peptide discovery powered by AI for specific health outcomes. Partner companies can access Nuritas's pipeline of intelligent ingredients in development and be first to access next generation ingredients.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B ingredient sales - quote-based pricing

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Nuritas product offering

Product offering

Core offering

Nuritas develops and sells clinically validated bioactive peptide ingredients (PeptiStrong®, PeptiSleep™, PeptiYouth™, PeptiProtect®) discovered through its proprietary Magnifier NπΦ™ AI platform. These plant-derived peptide ingredients are sold B2B to consumer-goods companies for formulation into functional foods, beverages, dietary supplements, and cosmetic products, supported by custom peptide discovery partnerships for major brands.

Product overview

Nuritas is a biotechnology company that developed a portfolio of clinically proven, AI-discovered peptide ingredients. The core offering consists of PeptiStrong® (muscle health), PeptiSleep™ (sleep quality), PeptiYouth™ (skin health), and PeptiProtect® (topical protection), all discovered and validated through the company's proprietary Magnifier NπΦ™ AI platform. The company operates as a B2B ingredient supplier, selling clinically validated peptide powders to consumer brands for integration into supplements, functional foods, beverages, and topical products. Over 100 consumer products now contain Nuritas SmartPeptides™, with commercial availability in more than 31 countries.

Differentiator

Problem solved

Functional benefit

Brands

  • PeptiStrong: Plant-based peptide ingredient derived from fava beans for muscle health and performance, backed by clinical studies supporting strength, energy, and recovery.
  • PeptiSleep
  • PeptiYouth
  • PeptiProtect
  • Magnifier

Products and services

  • PeptiStrong® Clinically studied plant-based bioactive peptide ingredient derived from fava beans that supports muscle strength, energy, and recovery. Sold B2B to consumer-goods, sports nutrition, and supplement brands (Cellucor, MuscleTech, Jacked Factory, Designs for Health, Nu Skin, GNC, Vitamin Shoppe) for formulation into functional foods, beverages, and supplements.
  • PeptiSleep™ Plant-based bioactive peptide ingredient designed to support sleep quality and circadian rhythm, backed by clinical research. Sold B2B to consumer brands for incorporation into sleep-support supplements and functional beverages.
  • PeptiYouth™ Plant-based bioactive peptide ingredient derived from rice proteins for skin health and beauty-from-within anti-aging applications. Validated through peer-reviewed research and sold B2B to cosmetics and supplement brands.
  • PeptiProtect® Plant-based peptide ingredient for protective health benefits, used in oral and topical product formats. Sold B2B to consumer brands for protective functional applications.
  • PeptiSave™ Antimicrobial peptide ingredient derived from peas, with demonstrated efficacy against foodborne pathogens including Escherichia coli O157:H7. Published in Frontiers in Microbiology and Food Science & Nutrition. Positioned as a research-stage antimicrobial peptide for food safety applications.
  • Custom Peptide Discovery Partnerships B2B service offering where Nuritas applies its Magnifier AI platform to discover novel bioactive peptides tailored to a partner's specified health outcomes. Provides partners with early access to next-generation ingredients and exclusive pipeline opportunities. Customers include BASF Human Nutrition and other major CPG/ingredient companies.

Quantifiable outcome

  • Discovery timeline reduced from 20-70 years to months
  • +5 more outcomes

Companies that use Nuritas

Customer profile

Named customers10 records

Segments3 records

Ideal customer profiles3 records

Nuritas technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature3 records

Nuritas partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and major.

  • MetaboTwin ConsortiumcoreStrategic or Co-development Partner · 10 June 2026Four-year TKI Agri & Food-funded research consortium led by Wageningen University & Research and Eindhoven University of Technology. Nuritas contributes food peptide ingredients for the world's first Human Dietary Digital Twin project studying metabolic responses to different protein sources.
  • Liverpool John Moores UniversitycoreStrategic or Co-development Partner · 24 April 2026Double-blinded RCT partnership examining PeptiStrong's ability to support healthy aging in adults aged 60-85, in collaboration with StudySetGo. Results expected Q3 2026.
  • AlifarmamajorChannel Partner/ Reseller/ Distributor · 24 April 2026European distribution partner for Spain and Portugal markets.
  • FaravellimajorChannel Partner/ Reseller/ Distributor · 24 April 2026European distribution partner for Italy market.
  • Vivatis PharmamajorChannel Partner/ Reseller/ Distributor · 24 April 2026European distribution partner for Poland, Czech Republic, Slovakia, and the three Baltic markets.
  • NestlécoreStrategic or Co-development PartnerMajor consumer goods company partnership for ingredient development and product integration.
  • MarscoreStrategic or Co-development PartnerMajor consumer goods company partnership for ingredient development and product integration.
  • GivaudancoreStrategic or Co-development PartnerLeading flavor and fragrance company partnership for ingredient innovation and product applications.
  • Sumitomo CorporationmajorStrategic or Co-development PartnerJapanese trading company partnership for ingredient distribution and market expansion.
  • BASFmajorStrategic or Co-development PartnerPartnership collaboration with BASF Human Nutrition. Vice President Tina Low quoted on consumer demand for plant-based solutions for sports-related inflammation.

Scale indicators8 records

Recent moves8 records

Expansion highlights8 records

Nuritas competitors and assessment

Company assessment

Emerging players

  • Phytolon: Phytolon uses precision fermentation to produce natural food colors from plants, an emerging player in AI/biotech-enabled food ingredients with similar go-to-market into CPG.
  • Amai Proteins: Amai uses computational protein design and AI to create sweet-protein and functional food proteins, an emerging peer that overlaps with Nuritas' AI-driven bioactive ingredient pipeline.
  • MycoTechnology: MycoTechnology uses fermentation platforms to develop plant-based functional food ingredients, an adjacent emerging player in the CPG ingredient space where Nuritas competes.

Direct peers

  • Brightseed: Brightseed uses AI to discover bioactive compounds in plants for food, beverage, and supplement applications, closely mirroring Nuritas' AI-discovered bioactive peptide model and B2B ingredient commercialization approach.
  • Shiru: Shiru applies AI to discover and design novel food proteins and ingredients, comparable to Nuritas' Magnifier-driven peptide discovery and B2B ingredient supply into CPG.
  • Geltor: Geltor produces animal-free functional proteins (including collagen-equivalent peptides) via precision fermentation, competing with Nuritas in the bioactive protein/peptide ingredient space for beauty and nutrition applications.

Broad incumbents

  • ADM (Health & Wellness / Biopolis): ADM is a global CPG ingredient powerhouse with a fast-growing Health & Wellness and microbiome/probiotic portfolio, representing a broad incumbent competitor in the branded functional-ingredient space.
  • Kerry Group: Kerry is a global taste and nutrition ingredient supplier serving the same CPG and supplement customers as Nuritas, with broader portfolios across functional foods and beverages.
  • IFF (Health & Biosciences): International Flavors & Fragrances has a large Health & Biosciences division producing bioactive ingredients (including proteins, enzymes, and cultures) for food, beverage, and supplement customers, overlapping with Nuritas' customer set.
  • BASF Human Nutrition: BASF is a global nutrition ingredient supplier and an existing Nuritas partner; it competes in the broader bioactive and plant-based ingredient market that Nuritas addresses.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Nuritas social profiles

Digital presence

Nuritas compliance and trust

Trust signal

Compliance2 records

Nuritas financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nuritas leadership team

Management profile

Number of profiles

Profiles13 records

Nuritas funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors17 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nuritas M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nuritas

What does Nuritas do?

Nuritas develops and sells clinically validated bioactive peptide ingredients (PeptiStrong®, PeptiSleep™, PeptiYouth™, PeptiProtect®) discovered through its proprietary Magnifier NπΦ™ AI platform. These plant-derived peptide ingredients are sold B2B to consumer-goods companies for formulation into functional foods, beverages, dietary supplements, and cosmetic products, supported by custom peptide discovery partnerships for major brands.

Is Nuritas a public or private company?

Nuritas is a private company. It is classified as venture growth investor backed and is currently operating.

When was Nuritas founded?

Nuritas was founded in 2014. It employs 51 to 100 people.

Where is Nuritas based?

Nuritas is headquartered in Dublin, Ireland, in the Europe region.

How does Nuritas make money?

Two revenue lines are on record. Peptide Ingredient Sales are the primary driver. The others are custom Peptide Discovery Partnerships.

Who are Nuritas's main competitors?

Emerging players on record are Phytolon, Amai Proteins and MycoTechnology. Direct peers are Brightseed, Shiru and Geltor. Broad incumbents are ADM (Health & Wellness / Biopolis), Kerry Group, IFF (Health & Biosciences) and BASF Human Nutrition.

Does Nuritas have an API?

No public API is recorded for Nuritas.

What industry is Nuritas in?

Nuritas's product category is Bioactive Peptide Ingredients. Its primary akta.pro industry code is AFAJAKAG, Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine), with a secondary code of AFAJAHAI, Protein Hydrolysates & Peptides (Enzymatic Hydrolysates, Bioactive Peptides). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Silicon RepublicIrish biotech Nuritas to partner with UL to develop next gen of scientistsNuritas, an Irish biotech, will partner with the University of Limerick's iBio programme as a founding industry residency partner. The four-year programme offers a master's degree and up to two years of paid industry experience. The partnership gives Nuritas access to the first cohort of students and educators.IrishtechnewsNuritas and University of Limerick partner to develop Ireland’s future scientistsNuritas, a peptide intelligence company, partnered with the University of Limerick as a Founding Industry Residency Partner for its iBio programme. The four-year integrated BSc/MSc degree includes up to two years of paid industry experience. The collaboration aims to equip Irish scientists with skills to translate research into impact.PR NewswireNuritas nomme Kees Kruythoff, ancien président d'Unilever Amérique du Nord, au poste de président du conseil d'administrationNuritas named Kees Kruythoff, former Unilever executive, as president of its board. He brings nearly 30 years of international leadership experience, including roles at Unilever America and Home Care. He will work with CEO Nora Khaldi to expand Nuritas's peptide portfolio and partnerships.PR NewswireNuritas ernennt ehemaligen Unilever North America President Kees Kruythoff zum Chairman of the BoardNuritas appointed Kees Kruythoff, former Unilever North America president, as chairman of its board. He brings nearly three decades of international leadership experience, including roles in home care and Brazil and South Africa. He will advise on expanding commercial partnerships and strengthening Nuritas's position at the intersection of AI, biotech, and health.Third NewsNuritas Welcomes Kees Kruythoff as New Board Chair to Drive Growth and InnovationNuritas appointed Kees Kruythoff, former Unilever North America president, as board chair. He brings nearly 30 years of global leadership experience, including overseeing the Home Care division. The appointment aims to drive growth and innovation as Nuritas expands its peptide portfolio.PR NewswireNuritas Appoints Former Unilever North America President Kees Kruythoff as Board ChairNuritas appointed Kees Kruythoff, former Unilever North America president, as board chair. He brings nearly 30 years of global leadership experience, including roles in Brazil and South Africa. He will work with CEO Nora Khaldi to expand commercial partnerships and peptide portfolio reach.PR NewswireNuritas nombra a Kees Kruythoff, expresidente de Unilever Norteamérica, presidente del Consejo de DirecciónNuritas named Kees Kruythoff, former Unilever North America president, as president of its board. He brings nearly 30 years of international leadership experience, including roles in home care and operations in Brazil and South Africa. He will work with founder Nora Khaldi to expand commercial reach and strengthen partnerships.PR NewswireNuritas Appoints Former Unilever North America President Kees Kruythoff as Board ChairNuritas appointed Kees Kruythoff, former Unilever North America president, as board chair. He brings nearly 30 years of global leadership experience, including roles in Brazil and South Africa. He will work with CEO Nora Khaldi to expand commercial partnerships and peptide portfolio reach.PR Newswire APACNuritas Appoints Former Unilever North America President Kees Kruythoff as Board ChairNuritas appointed Kees Kruythoff, former Unilever North America president, as board chair. He brings nearly 30 years of global leadership experience, including roles in Brazil and South Africa. He will work with CEO Nora Khaldi to expand commercial partnerships and peptide portfolio.NewswireNuritas Appoints Former Unilever North America President Kees Kruythoff as Board ChairNuritas appointed Kees Kruythoff, former Unilever North America president, as board chair. He brings nearly 30 years of global leadership experience, including roles in Brazil and South Africa. He will work with CEO Nora Khaldi to expand commercial partnerships and peptide portfolio.